Kyung‐Ran Park

2.4k total citations
78 papers, 2.0k citations indexed

About

Kyung‐Ran Park is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Kyung‐Ran Park has authored 78 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Pharmacology. Recurrent topics in Kyung‐Ran Park's work include Bone Metabolism and Diseases (19 papers), Bone health and treatments (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Kyung‐Ran Park is often cited by papers focused on Bone Metabolism and Diseases (19 papers), Bone health and treatments (9 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Kyung‐Ran Park collaborates with scholars based in South Korea, United States and Singapore. Kyung‐Ran Park's co-authors include Hyung‐Mun Yun, Jin Tae Hong, Eun-Cheol Kim, Kwang Seok Ahn, Hyeung-Jin Jang, Dongwoo Nam, Seok‐Geun Lee, Sang‐Bae Han, Somi K. Cho and Eun-Cheol Kim and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biomaterials.

In The Last Decade

Kyung‐Ran Park

76 papers receiving 2.0k citations

Peers

Kyung‐Ran Park
Fei Gao China
Ying Nie China
Jun Peng China
Xue Jiang China
Sik Yoon South Korea
Xue Xia China
Fei Gao China
Kyung‐Ran Park
Citations per year, relative to Kyung‐Ran Park Kyung‐Ran Park (= 1×) peers Fei Gao

Countries citing papers authored by Kyung‐Ran Park

Since Specialization
Citations

This map shows the geographic impact of Kyung‐Ran Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung‐Ran Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung‐Ran Park more than expected).

Fields of papers citing papers by Kyung‐Ran Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung‐Ran Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung‐Ran Park. The network helps show where Kyung‐Ran Park may publish in the future.

Co-authorship network of co-authors of Kyung‐Ran Park

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung‐Ran Park. A scholar is included among the top collaborators of Kyung‐Ran Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung‐Ran Park. Kyung‐Ran Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Kyung‐Ran, et al.. (2025). ST1936 stimulates osteoclastogenesis and suppresses osteoclastic apoptosis through the ERK1/2 signaling pathway in bone marrow–derived macrophages. International Immunopharmacology. 157. 114753–114753. 1 indexed citations
2.
Yun, Hyung‐Mun, et al.. (2024). Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma. International Journal of Molecular Sciences. 25(7). 3582–3582. 3 indexed citations
3.
Park, Kyung‐Ran, Hyung‐Mun Yun, & Jin Tae Hong. (2020). G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway. International Journal of Biological Sciences. 16(2). 330–341. 31 indexed citations
4.
Park, Kyung‐Ran, Hyung‐Mun Yun, Kyeong‐Won Yoo, et al.. (2020). Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis. Cell Communication and Signaling. 18(1). 5–5. 14 indexed citations
5.
Park, Kyung‐Ran & Hyung‐Mun Yun. (2019). RANKL-induced osteoclastogenesis in bone marrow-derived macrophages is suppressed by cisapride. Toxicology. 422. 95–101. 19 indexed citations
6.
Park, Kyung‐Ran, Eun-Cheol Kim, Jin Tae Hong, & Hyung‐Mun Yun. (2018). Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss. Theranostics. 8(11). 3087–3098. 55 indexed citations
7.
Yun, Hyung‐Mun, Kyung‐Ran Park, Trần Hồng Quang, et al.. (2017). 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells. Archives of Pharmacal Research. 40(5). 601–609. 14 indexed citations
8.
Yun, Hyung‐Mun, Peng Jin, Kyung‐Ran Park, et al.. (2015). Thiacremonone Potentiates Anti-Oxidant Effects to Improve Memory Dysfunction in an APP/PS1 Transgenic Mice Model. Molecular Neurobiology. 53(4). 2409–2420. 20 indexed citations
9.
Yun, Hyung‐Mun, Kyung‐Ran Park, Mi Hee Park, et al.. (2015). PRDX6 promotes tumor development via the JAK2/STAT3 pathway in a urethane-induced lung tumor model. Free Radical Biology and Medicine. 80. 136–144. 51 indexed citations
10.
Park, Kyung‐Ran, et al.. (2013). Anatomic study to determine a safe surgical reference point for mandibular ramus osteotomy. Journal of Cranio-Maxillofacial Surgery. 42(1). 22–27. 23 indexed citations
12.
Park, Hyoung Suk, Kyung‐Ran Park, Kyung Sang Kim, et al.. (2012). Inpainting based metal reduction in dental X-ray computed tomography. 7(1). 203–204. 2 indexed citations
13.
Park, Kyung‐Ran, Sung‐Moo Kim, Hyung‐Mun Yun, et al.. (2012). A Hexane Fraction of Guava Leaves ( Psidium guajava L.) Induces Anticancer Activity by Suppressing AKT/Mammalian Target of Rapamycin/Ribosomal p70 S6 Kinase in Human Prostate Cancer Cells. Journal of Medicinal Food. 15(3). 231–241. 72 indexed citations
14.
Park, Kyung‐Ran, Sang Yoon Kim, Hyung-Sik Park, & Young‐Soo Jung. (2012). Surgery-first approach on patients with temporomandibular joint disease by intraoral vertical ramus osteotomy. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(6). e429–e436. 21 indexed citations
15.
Park, Kyung‐Ran, Dongwoo Nam, Hyung‐Mun Yun, et al.. (2011). β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letters. 312(2). 178–188. 282 indexed citations
16.
Kim, Sung‐Moo, Kyung‐Ran Park, Sang‐Yoon Park, et al.. (2011). Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN. Cancer Letters. 308(1). 71–80. 79 indexed citations
17.
Park, Kyung‐Ran & Ho Ran Park. (2005). A Study on the Employment Stress in Senior-year University Students. Journal of Korean Public Health Nursing. 19(2). 329–339. 2 indexed citations
18.
Park, Kyung‐Ran, et al.. (2003). Involvement of Organic Acid During Corrosion of Iron Coupon by Desulfovibrio desulfuricans. Journal of Microbiology and Biotechnology. 13(6). 937–941. 16 indexed citations
19.
Lee, Ik Jae, et al.. (2002). Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 54(3). 768–779. 47 indexed citations
20.
Chung, Jaesik, et al.. (2001). Effect of Poly(butyl acrylate)-Poly(methyl methacrylate) Rubber Particle Texture on the Toughening Behavior of Poly(methyl methacrylate). Macromolecular Research. 9(2). 122–128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026